JP2023535771A5 - - Google Patents

Info

Publication number
JP2023535771A5
JP2023535771A5 JP2023505421A JP2023505421A JP2023535771A5 JP 2023535771 A5 JP2023535771 A5 JP 2023535771A5 JP 2023505421 A JP2023505421 A JP 2023505421A JP 2023505421 A JP2023505421 A JP 2023505421A JP 2023535771 A5 JP2023535771 A5 JP 2023535771A5
Authority
JP
Japan
Application number
JP2023505421A
Other languages
Japanese (ja)
Other versions
JPWO2022026285A5 (https=
JP7695339B2 (ja
JP2023535771A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/042711 external-priority patent/WO2022026285A1/en
Publication of JP2023535771A publication Critical patent/JP2023535771A/ja
Publication of JPWO2022026285A5 publication Critical patent/JPWO2022026285A5/ja
Publication of JP2023535771A5 publication Critical patent/JP2023535771A5/ja
Application granted granted Critical
Publication of JP7695339B2 publication Critical patent/JP7695339B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023505421A 2020-07-27 2021-07-22 インフルエンザを治療又は予防するための多環式キャップ依存性エンドヌクレアーゼ阻害薬 Active JP7695339B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063056861P 2020-07-27 2020-07-27
US63/056,861 2020-07-27
PCT/US2021/042711 WO2022026285A1 (en) 2020-07-27 2021-07-22 Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza

Publications (4)

Publication Number Publication Date
JP2023535771A JP2023535771A (ja) 2023-08-21
JPWO2022026285A5 JPWO2022026285A5 (https=) 2024-06-17
JP2023535771A5 true JP2023535771A5 (https=) 2024-06-17
JP7695339B2 JP7695339B2 (ja) 2025-06-18

Family

ID=80038102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505421A Active JP7695339B2 (ja) 2020-07-27 2021-07-22 インフルエンザを治療又は予防するための多環式キャップ依存性エンドヌクレアーゼ阻害薬

Country Status (10)

Country Link
US (1) US20240018145A1 (https=)
EP (1) EP4188379B1 (https=)
JP (1) JP7695339B2 (https=)
KR (1) KR20230044252A (https=)
CN (1) CN116490190A (https=)
AU (1) AU2021315475A1 (https=)
BR (1) BR112023001325A2 (https=)
CA (1) CA3187516A1 (https=)
MX (1) MX2023001194A (https=)
WO (1) WO2022026285A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118804908A (zh) * 2022-03-01 2024-10-18 弗门尼舍有限公司 制备γ,δ-不饱和醛衍生物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
EA200801144A1 (ru) 2005-10-27 2008-10-30 Сионоги Энд Ко., Лтд. Полициклическое карбамоилпиридоновое производное, обладающее ингибиторной активностью в отношении интегразы вич
MX2013003139A (es) 2010-09-24 2013-06-18 Shionogi & Co Profarmaco de derivado de carbamoilpiridona policiclica substituida.
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
EP4257137A3 (en) * 2018-05-31 2023-11-01 Shionogi & Co., Ltd Polycyclic carbamoylpyridone derivatives for the treatment of hiv
AU2019277547B2 (en) 2018-05-31 2024-10-10 Shionogi & Co., Ltd. Polycyclic pyridone derivative
CN113286793B (zh) 2018-09-10 2024-04-05 共结晶制药公司 吡咯并吡嗪和吡啶并三嗪类流感病毒复制抑制剂

Similar Documents

Publication Publication Date Title
JP2023535771A5 (https=)
BR102021012571A2 (https=)
CN305531375S (https=)
CN305528444S (https=)
CN305537093S (https=)
CN305536973S (https=)
CN305536294S (https=)
CN305535713S (https=)
CN305535307S (https=)
CN305534807S (https=)
CN305763997S (https=)
CN305534465S (https=)
CN305533835S (https=)
CN305533494S (https=)
CN305533452S (https=)
CN305532648S (https=)
CN305531891S (https=)
CN305530433S (https=)
CN306394700S (https=)
CN306168481S (https=)
CN306167627S (https=)
CN306165816S (https=)
CN306164873S (https=)
CN306164042S (https=)
CN306152259S (https=)